Open AccessSpontaneous rectus sheath hematoma during rivaroxaban therapy
Author(s) -
İbrahim Kocayiğit,
Yusuf Can,
Salih Şahinkuş,
Ercan Aydın,
Mehmet Bülent Vatan,
Harun Kılıç,
Hüseyin Gündüz
Publication year - 2014
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.132193
Subject(s) - rivaroxaban , medicine , coagulation cascade , atrial fibrillation , hematoma , oral anticoagulant , venous thrombosis , anticoagulant , thrombosis , surgery , cardiology , anesthesia , warfarin , thrombin , platelet
Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman.